W. Birkenhäger

Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial

J. Tuomilehto, J. Staessen, L. Thijs, 2001, Journal of Human Hypertension.

Adrenergic vasoconstriction as a cause of inadequate hypotensive response to beta-adrenergic blockade.

P. Deleeuw, W. Birkenhäger, 1983, Hypertension.

Antihypertensive therapy in elderly patients with isolated systolic hypertension: third progress report of the Syst-Eur trial.

C. Bulpitt, A. Amery, L. Thijs, 1993, Clinical and experimental hypertension.

Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.

A. Breckenridge, A. Amery, E. Frohlich, 1988, Hypertension.

Reversal of rhythmic water and sodium excretion patterns during ganglionic or adrenergic block.

W. Birkenhäger, L. A. Vries, L. W. S. Eps, 2009 .

Cerebral complications of hypertension

J. Staessen, W. Birkenhäger, F. Forette, 2000, Journal of Human Hypertension.

Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress

J. Webster, J. Tuomilehto, J. Staessen, 1999, Journal of Human Hypertension.